Publicacions en què col·labora amb Guillermo Reglero Rada (10)

2015

  1. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer

    European Journal of Cancer, Vol. 51, Núm. 1, pp. 1-8

  2. ColoLipidGene: Signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

    Oncotarget, Vol. 6, Núm. 9, pp. 7348-7363

  3. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy

    Nutrition and Cancer, Vol. 67, Núm. 8, pp. 1223-1231

  4. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16

    Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 2, pp. 433-444

2014

  1. Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer

    PLoS ONE, Vol. 9, Núm. 6

  2. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer

    Molecular Oncology, Vol. 8, Núm. 8, pp. 1469-1481

  3. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells

    Electrophoresis, Vol. 35, Núm. 11, pp. 1719-1727

2013

  1. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells

    Pharmacological Research, Vol. 72, pp. 61-68

  2. Supercritical rosemary extracts, their antioxidant activity and effect on hepatic tumor progression

    Journal of Supercritical Fluids, Vol. 79, pp. 101-108

2010

  1. Nutritional Genomics for the Determination of the Mechanism of Action of the Beneficial Effect of Bioactive Extracts in Tumor Progression

    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS